Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12416010-B2

Patent

Publication Date

2025-09-16

Expiration Date


Abstract

This invention relates to gene expression regulatory sequences, specifically transcription terminator sequences. Plant transcription terminator sequences are described herein. Methods for identifying novel plant transcription terminator sequences that can terminate transcription in one orientation or in a bidirectional manner and methods of using these terminator sequences to generate transgenic plants are described herein.

Core Innovation

The disclosure relates to plant transcription terminator regulatory sequences and their use in recombinant constructs to terminate transcription in a plant cell. The terminator comprises a nucleotide sequence as set forth in SEQ ID NO: 18 or 28, or a functional fragment of at least 200 contiguous nucleotides of SEQ ID NO: 18 or 28 having terminator activity. The polynucleotide functions as a bidirectional transcriptional terminator in a plant cell.

The bidirectional transcriptional terminator is operably linked to the 3′ end of a first heterologous polynucleotide that is operably linked to a first promoter and to the 3′ end of a second heterologous polynucleotide that is operably linked to a second promoter. The first and the second heterologous polynucleotides are transcribed in a convergent manner, providing a transcription termination arrangement for convergent transcription in the plant cell.

The document further describes identification and validation of candidate terminators in the context of convergent gene pairs and recombinant construct testing. Candidate plant terminators are defined by sequence identity and by functional fragments, and their performance is evaluated using a terminator test vector driving GUS and measuring read-through transcription and comparing read-through and GUS protein levels against a PINII terminator control. Shorter constituent or truncated bidirectional terminators are derived based on polyadenylation site mapping and described with SEQ ID NO:129–162.

Claims Coverage

The independent claim set centers on a recombinant construct that functions as a bidirectional transcriptional terminator in a plant cell for convergently transcribed heterologous polynucleotides, with dependent claims further defining plant/seed embodiments and transgenic/progeny outcomes. The main independent claim is clm-00001.

Bidirectional transcriptional terminator for convergent transcription in plant cells

A recombinant construct comprising a polynucleotide having terminator activity that functions as a bidirectional transcriptional terminator in a plant cell, wherein the polynucleotide is operably linked to the 3′ end of a first heterologous polynucleotide operably linked to a first promoter and to the 3′ end of a second heterologous polynucleotide operably linked to a second promoter, and wherein the first and the second heterologous polynucleotides are transcribed in a convergent manner.

Recombinant-construct-containing plant

A plant comprising in its genome the recombinant construct of the bidirectional transcriptional terminator for convergent transcription in plant cells.

Seed including the recombinant construct

A seed that includes the recombinant construct of the bidirectional transcriptional terminator for convergent transcription in plant cells, the seed taken from the recombinant-construct-containing plant.

Plant species-selected embodiment

The plant is selected from the group consisting of Arabidopsis, maize, soybean, sunflower, sorghum, canola, mustard, wheat, alfalfa, cotton, rice, barley, millet, sugar cane, and switchgrass.

Overall claim coverage focuses on a bidirectional transcriptional terminator polynucleotide operably positioned at the 3′ ends of two convergently transcribed heterologous polynucleotides in a plant cell, with further coverage to plants and seeds containing the construct, and to specific plant species listed in the dependent claim set.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.